Pfizer's profits continue to struggle into the second quarter
This article was originally published in Scrip
Executive Summary
Pfizer's second-quarter profits fell by 19% following widespread declines across its marketed products and the burden of adverse currency exchange rates. Net profits sunk to $2.26 billion as exchange rates knocked $1.1 billion from its revenues and key drug sales fell by double digits.